| Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ... Annals of neurology 89 (4), 780-789, 2021 | 468 | 2021 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 369 | 2015 |
| Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PloS one 7 (10), e48078, 2012 | 261 | 2012 |
| Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ... Annals of neurology 80 (1), 89-100, 2016 | 205 | 2016 |
| Predictors and dynamics of postpartum relapses in women with multiple sclerosis SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ... Multiple Sclerosis Journal 20 (6), 739-746, 2014 | 204 | 2014 |
| Treatment decisions in multiple sclerosis—insights from real-world observational studies M Trojano, M Tintore, X Montalban, J Hillert, T Kalincik, P Iaffaldano, ... Nature Reviews Neurology 13 (2), 105-118, 2017 | 185 | 2017 |
| Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis M Trojano, F Pellegrini, D Paolicelli, A Fuiani, GB Zimatore, C Tortorella, ... Annals of neurology 66 (4), 513-520, 2009 | 171 | 2009 |
| Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial MP Amato, B Goretti, RG Viterbo, E Portaccio, C Niccolai, B Hakiki, ... Multiple Sclerosis Journal 20 (1), 91-98, 2014 | 144 | 2014 |
| Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study P Iaffaldano, RG Viterbo, D Paolicelli, G Lucchese, E Portaccio, B Goretti, ... PloS one 7 (4), e35843, 2012 | 114 | 2012 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 104 | 2021 |
| Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis L Prosperini, RP Kinkel, AA Miravalle, P Iaffaldano, S Fantaccini Therapeutic advances in neurological disorders 12, 1756286419837809, 2019 | 94 | 2019 |
| Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis P Iaffaldano, G Lucisano, C Pozzilli, V Brescia Morra, A Ghezzi, ... Brain 138 (11), 3275-3286, 2015 | 85 | 2015 |
| Anxiety state affects information processing speed in patients with multiple sclerosis B Goretti, RG Viterbo, E Portaccio, C Niccolai, B Hakiki, E Piscolla, ... Neurological sciences 35, 559-563, 2014 | 79 | 2014 |
| Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies P Iaffaldano, G Lucisano, F Caputo, D Paolicelli, F Patti, M Zaffaroni, ... Therapeutic Advances in Neurological Disorders 14, 17562864211019574, 2021 | 75 | 2021 |
| Multiple sclerosis registries in Europe–An updated mapping survey A Glaser, A Stahmann, T Meissner, P Flachenecker, D Horáková, ... Multiple sclerosis and related disorders 27, 171-178, 2019 | 75 | 2019 |
| The impact of neutralizing antibodies on the risk of disease worsening in interferon β–treated relapsing multiple sclerosis: a 5 year post-marketing study D Paolicelli, M D’Onghia, F Pellegrini, V Direnzo, P Iaffaldano, V Lavolpe, ... Journal of neurology 260, 1562-1568, 2013 | 66 | 2013 |
| Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis MP Amato, M Fonderico, E Portaccio, L Pastò, L Razzolini, E Prestipino, ... Brain 143 (10), 3013-3024, 2020 | 64 | 2020 |
| Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study E Portaccio, A Bellinvia, M Fonderico, L Pastò, L Razzolini, R Totaro, ... Brain 145 (8), 2796-2805, 2022 | 53 | 2022 |
| Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender S Zoccolella, C Tortorella, P Iaffaldano, V Direnzo, M D’Onghia, ... Journal of neurology 259, 2105-2110, 2012 | 53 | 2012 |
| Computer-assisted rehabilitation of attention in pediatric multiple sclerosis and ADHD patients: a pilot trial M Simone, RG Viterbo, L Margari, P Iaffaldano BMC neurology 18, 1-11, 2018 | 50 | 2018 |
